Please wait while the formulary information is being retrieved.
GVOKE SYRINGE (glucagon)
- Hypoglycemic disorder
0.5 mg/0.1 mL subcutaneous syringe
- Dosage information is not available
1 mg/0.2 mL subcutaneous syringe
- Inject 0.2 milliliter (1 mg) by subcutaneous route once in the abdomen, thigh, or upper arm may repeat in 15 minutes if inadequate response
Hypoglycemic disorder
- Inject 1 mg by subcutaneous route once in the abdomen, thigh, or upper arm may repeat in 15 minutes if inadequate response
- Inject 0.2 milliliter (1 mg) by subcutaneous route once in the abdomen, thigh, or upper arm may repeat in 15 minutes if inadequate response
- None
Contraindicated
- None
Severe
Moderate
- Coumadin
- Jantoven
- warfarin
- Insulinoma
- Pheochromocytoma
Contraindicated
- Glucagonoma
Severe
Moderate
- None
GVOKE SYRINGE (glucagon)
- Hypoglycemic disorder
- None
- Injection site sequelae
More Frequent
Severe
Less Severe
- None
- Diarrhea
- Dizziness
- Drowsy
- General weakness
- Headache disorder
- Nausea
- Pallor
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute respiratory distress syndrome
- Anaphylaxis
- Hypertension
- Hypotension
- Necrolytic migratory erythema
Less Severe
- Skin rash
- Tachycardia
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Glucagon (subcutaneous)
Safety and effectiveness not established in age < 2 years.
- 1 Day – 2 Years
- Safety and effectiveness not established in age < 2 years.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Glucagon
Minimal risk to infant;Short half-life, drug destroyed in gi tract
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Minimal risk to infant;Short half-life, drug destroyed in gi tract |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Hypoglycemic disorder | |
| E08.64 | Diabetes mellitus due to underlying condition with hypoglycemia |
| E08.649 | Diabetes mellitus due to underlying condition with hypoglycemia without coma |
| E09.64 | Drug or chemical induced diabetes mellitus with hypoglycemia |
| E09.649 | Drug or chemical induced diabetes mellitus with hypoglycemia without coma |
| E10.64 | Type 1 diabetes mellitus with hypoglycemia |
| E10.649 | Type 1 diabetes mellitus with hypoglycemia without coma |
| E11.64 | Type 2 diabetes mellitus with hypoglycemia |
| E11.649 | Type 2 diabetes mellitus with hypoglycemia without coma |
| E13.64 | Other specified diabetes mellitus with hypoglycemia |
| E13.649 | Other specified diabetes mellitus with hypoglycemia without coma |
| E16.0 | Drug-induced hypoglycemia without coma |
| E16.1 | Other hypoglycemia |
| E16.2 | Hypoglycemia, unspecified |
| P70.3 | Iatrogenic neonatal hypoglycemia |
| P70.4 | Other neonatal hypoglycemia |
| 0-9 | A-Z |
|---|---|
| E08.64 | Diabetes mellitus due to underlying condition with hypoglycemia |
| E08.649 | Diabetes mellitus due to underlying condition with hypoglycemia without coma |
| E09.64 | Drug or chemical induced diabetes mellitus with hypoglycemia |
| E09.649 | Drug or chemical induced diabetes mellitus with hypoglycemia without coma |
| E10.64 | Type 1 diabetes mellitus with hypoglycemia |
| E10.649 | Type 1 diabetes mellitus with hypoglycemia without coma |
| E11.64 | Type 2 diabetes mellitus with hypoglycemia |
| E11.649 | Type 2 diabetes mellitus with hypoglycemia without coma |
| E13.64 | Other specified diabetes mellitus with hypoglycemia |
| E13.649 | Other specified diabetes mellitus with hypoglycemia without coma |
| E16.0 | Drug-induced hypoglycemia without coma |
| E16.1 | Other hypoglycemia |
| E16.2 | Hypoglycemia, unspecified |
| P70.3 | Iatrogenic neonatal hypoglycemia |
| P70.4 | Other neonatal hypoglycemia |
Formulary Reference Tool